These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3316337)

  • 1. Frequency-dependent ultrasonic differentiation of normal and diffusely diseased liver.
    Lin T; Ophir J; Potter G
    J Acoust Soc Am; 1987 Oct; 82(4):1131-8. PubMed ID: 3316337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of ultrasonic attenuation with pathologic fat and fibrosis in liver disease.
    Lin T; Ophir J; Potter G
    Ultrasound Med Biol; 1988; 14(8):729-34. PubMed ID: 3062866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo measurements of ultrasound attenuation in normal or diseased liver.
    Parker KJ; Asztely MS; Lerner RM; Schenk EA; Waag RC
    Ultrasound Med Biol; 1988; 14(2):127-36. PubMed ID: 3279691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency domain processing for ultrasonic attenuation measurement in liver.
    Wilson LS; Robinson DE; Doust BD
    Ultrason Imaging; 1984 Jul; 6(3):278-92. PubMed ID: 6396922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography and water content of the liver in chronic diffuse liver disease.
    Szebeni A; Pintér E; Stotz G; Tolvaj G; Juhász M; Dávid K
    Acta Med Hung; 1990; 47(3-4):163-70. PubMed ID: 2130364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method.
    Itoh K; Yasuda Y; Suzuki O; Itoh H; Itoh T; Tsao JW; Konishi T; Koyano A
    J Clin Ultrasound; 1988 Oct; 16(8):553-62. PubMed ID: 3152399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of structural change in diffuse liver disease with frequency domain analysis of ultrasound.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Imai Y; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):1041-6. PubMed ID: 8514252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue characterization of the liver using ultrasound attenuation in an animal experiment].
    Drescher T; Letterer H; Richter KP
    Ultraschall Med; 1990 Apr; 11(2):104-8. PubMed ID: 2192448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation.
    Fusamoto H; Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Kamada T
    J Nutr Sci Vitaminol (Tokyo); 1991 Dec; 37 Suppl():S71-7. PubMed ID: 1820448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of ultrasonic attenuation of liver on pathologic fat and fibrosis: examination with experimental fatty liver and liver fibrosis models.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Fusamoto H; Imai Y; Kamada T
    Ultrasound Med Biol; 1992; 18(8):657-66. PubMed ID: 1440987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a narrowband estimator for acoustic attenuation in liver.
    Duerinckx AJ; Ferrari LA
    Ultrason Imaging; 1986 Jul; 8(3):225-6. PubMed ID: 3548003
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound attenuation measurements of the liver in vivo using a commercial sector scanner.
    Garra BS; Shawker TH; Nassi M; Russell MA
    Ultrason Imaging; 1984 Oct; 6(4):396-407. PubMed ID: 6399170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease.
    Garra BS; Insana MF; Shawker TH; Russell MA
    Radiology; 1987 Jan; 162(1 Pt 1):61-7. PubMed ID: 3538154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method.
    Fujii Y; Taniguchi N; Itoh K; Shigeta K; Wang Y; Tsao JW; Kumasaki K; Itoh T
    J Ultrasound Med; 2002 Jul; 21(7):783-8. PubMed ID: 12099567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurements of ultrasonic backscatter coefficients in human liver and kidney in vivo.
    Wear KA; Garra BS; Hall TJ
    J Acoust Soc Am; 1995 Oct; 98(4):1852-7. PubMed ID: 7593911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo acoustic attenuation in liver: correlations with blood tests and histology.
    Duerinckx A; Rosenberg K; Hoefs J; Aufrichtig D; Cole-Beuglet C; Kanel G; Lottenberg S; Ferrari LA
    Ultrasound Med Biol; 1988; 14(5):405-13. PubMed ID: 3051614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of ultrasound attenuation and histopathological parameters of the liver in chronic diffuse liver diseases.
    Szebeni A; Tolvaj G; Zalatnai A
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):37-42. PubMed ID: 16357617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Echomorphological comparisons in chronic diseases of the liver].
    Iakhontova OI; Dudanova OP; Gur'ianova SD; Popova TV
    Ter Arkh; 1989; 61(2):52-5. PubMed ID: 2658194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acoustic properties, centered on 20 MHZ, of an IEC agar-based tissue-mimicking material and its temperature, frequency and age dependence.
    Brewin MP; Pike LC; Rowland DE; Birch MJ
    Ultrasound Med Biol; 2008 Aug; 34(8):1292-306. PubMed ID: 18343021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.